KRT10 Antibody
Référence OAEE00368
Conditionnement : 0.1mg(C100)
Marque : Aviva Systems Biology
| Datasheets/Manuals | Printable datasheet for KRT10 Antibody |
|---|
| Predicted Species Reactivity | Cat|Human |
|---|---|
| Product Format | Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide |
| Clonality | Monoclonal |
| Clone | DE-K13 |
| Isotype | IgG2a |
| Host | Mouse |
| Application | IHC-Fr|IHC-P|WB |
| Reconstitution and Storage | 2°C to 8°C |
| Immunogen | Cytoskeletal preparation extracted from human ectocervical epithelium. |
| Purification | Purified |
| Concentration | 1 mg/ml |
| Specificity | The antibody DE-K13 reacts with Cytokeratin 10 (56.5 kDa) and Cytokeratin 13 (53 kDa). Cytokeratins are a member of intermediate filaments subfamily represented in epithelial tissues. DE-K13 recognizes only Cytokeratin 13 on formalin-fixed, paraffin-embedded tissue sections. |
| Formulation | Purified |
| Purity | > 95% (by SDS-PAGE) |
| Storage Buffer | Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4 |
| Reference | Ivanyi D, Minke JM, Hageman C, Groeneveld E, van Doornewaard G.: Patterns of expression of feline cytokeratins in healthy epithelia and mammary carcinoma cells. Am J Vet Res. 1992 Mar;53(3):304-14. Kozaki M, Nakamura Y, Iguchi M, Kano R, Watanabe S, Fujiwara K, Hasegawa A.: Immunohistochemical analysis of cytokeratin expression in dog skin. J Vet Med Sci. 2001 Jan;63(1):1-4. Ivanyi D, Minke JM, Hageman C, Groeneveld E, van Doornewaard G, Misdorp W.: Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas. Am J Vet Res. 1993 Jul;54(7):1095-102. |
|---|---|
| Gene Symbol | KRT10 |
| Gene Full Name | Keratin, type I cytoskeletal 10 |
| Alias Symbols | BIE, EHK, K10, KPP, BCIE, CK10 |
| NCBI Gene Id | 3858 |
| Protein Name | Keratin, type I cytoskeletal 10 |
| Uniprot ID | P13645 |
| Protein Accession # | NP_000412.3 |
| Nucleotide Accession # | NM_000421.3 |







